Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : America On-Line (AOL) -- Ignore unavailable to you. Want to Upgrade?

To: robert duke who wrote (5923)	2/27/1999 11:57:00 PM
From: Bretsky	Read Replies (1) \| Respond to of 41369

Thanks for the viewpoints. It looks like ou are well diversified. I'm a sales manager for a value added reseller in Wisconsin so that is why I'm in mostly tech stocks. Watch CSCO and WCOM for a downturn to get in; the are excellent ways to play the net. It'd also be a great idea to do some homework on EMC, the #2 best performing stock in the past 10 years. It is still growing at incredible rates, and still seems to be gaining market share.

To: robert duke who wrote (5923)	2/28/1999 9:09:00 AM
From: Craig A	Read Replies (1) \| Respond to of 41369

*OT ROBERT From today's Bear-ons Andrew Bary in The Trader column: 'But the chains, especially Walgreen, could be vulnerable if only because of their lofty price/earnings multiples. Walgreen trades at a stunning 53 times the profits projected for its current fiscal year, which ends in August. CVS has a P/E of 36, and Rite Aid, 24, based on expected 1999 profits. Walgreen shares are up 75% in the past year and have risen tenfold since 1990. Walgreen's ascent reflects its steady 15% annual profit growth, its allure as a demographic play on aging Baby Boomers, and investors' willingness to accord huge P/E multiples to companies with consistent double-digit profit growth. Walgreen is well-managed. But should it command a higher multiple than all the major drug makers except Pfizer? After all, the top drug outfits have better profit growth, higher margins and less competition. Walgreen's prescription-drug sales are growing smartly, but the company did warn in its latest 10-Q filing that its margins are under some pressure from rising third-party and mail-order sales' ***** That rag has been raining on my parade for a long time, but if it doesn't come from Abelson I do listen a bit. I sold WAG last week because of the huge run. The stock will definitely take a hit Monday due to the above. If you believe in its long term future, tomorrow might be the time to add more. I might re-enter. The article centered on AMZN getting into the drug retail and the effects that may have on the chains.You should get yourself a copy. I am concerned about the huge competition. I live in a very rural area and the local town has 4 discount RX on one intersection. Hope this is helpful. You contribute a ton to this thread. Can you hear it now? "You've got drugs!" Peace Craig